(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KALLESTAD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

KALLESTAD

ST13

US500000073004488

Class

1, 9

Filing

73004488

Registration

1037127

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

06/16/2026

Trademark type

Word

Nice classes

1, 9

Filing date

10/25/1973

Registration date

04/06/1976

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/27/2026

Last transaction

06/16/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/14/1968

First use in commerce

08/14/1968

Drawing code

1

Owner type

03

Owner location

HERCULES, CA, US

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIO-RAD LABORATORIES, INC.
SANOFI DIAGNOSTICS PASTEUR, INC.
KALLESTAD LABORATORIES, INC.

Representatives

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP

Technical classification

Nice Classes

Class 1Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

IMMUNOCHEMICALS; ANTILYMPHOCYTE GLOBULIN AND ASSOCIATED REAGENTS; AND BIOLOGICAL REAGENTS USED IN SEROLOGICAL AND IMMUNOLOGICAL DETERMINATIONS

Class 9

CLINICAL CHEMISTRY KITS CONSISTING OF REAGENTS AND COLOR STANDARDS FOR DETERMINATION OF CHOLESTEROLTRIGLYCERIDES AND LIPOPROTEIN; RADIOIMMUNOASSAY TEST KITS CONSISTING OF FUNCTIONAL AND CONTROL SERA; RADIAL DIFFUSION TEST KITS CONSISTING OF TEST PLATESREFERENCE SERA AND CAPILLARY PIPETTES FOR DETERMINATION OF IMMUNOGLOBULINHEPATITIS ASSOCIATED ANTIGENS (HAA)HAPTOGLOBINTRANSFERRINLYSOZOMEEQUINE GAMMA GLOBULINACCESSORIES-NAMELYSLIDE VIEWERSOPTICAL COMPARATORS AND MICRO PIPETTE SYSTEMS; AND INSTRUMENTS FOR USE IN ANALYZING BIOLOGICAL SUBSTANCES-NAMELYIMMUNO DIFFUSION CAMERASELECTROPHORESIS CELLSDIFFUSION CHAMBERSTEMPLATE BLOCKS FOR SLIDESLEVELING TABLESSLIDESSLIDE VIEWERSDIRECT CURRENT POWER SUPPLIES

Publications

History of USPTO decisions and trademark events.

22 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/27/2026

RNL4

REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)

05/27/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/27/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/27/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

03/22/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/06/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/07/2016

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

12/07/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/07/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/07/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

09/28/2016

CFIT

CASE FILE IN TICRS

10/26/2007

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

10/11/2006

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/11/2006

PLGL

ASSIGNED TO PARALEGAL

09/29/2006

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

07/13/2006

MAIL

PAPER RECEIVED

07/13/2006

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/14/2006

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/07/2006

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/06/1996

9.AF

REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8

03/20/1996

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/09/1982

Continuous trademark protection

Get notified about every new filing that threatens KALLESTAD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.